Both in Pharmaceuticals
Protagonist Therapeutics vs Madrigal Pharmaceuticals
Over the past year PTGX returned +87.4% and MDGL returned −9.9%; their daily moves had a correlation of 0.27.
PTGX +87.4% MDGL −9.9%Growth of $1, one year, split-adjusted
| Metric | PTGX | MDGL |
|---|---|---|
| Price | $143.37 | $400.43 |
| Market cap | $9.28B | $9.25B |
| Today | +2.23% | +1.04% |
| 1 month | +3.4% | −19.3% |
| 6 months | +37.9% | −25.8% |
| Year to date | +64.2% | −31.2% |
| 1 year | +88.8% | −2.9% |
| Revenue growth (YoY) | +3749.2% | +50.1% |
| Gross margin | 100.0% | 100.0% |
| Net margin | 76.3% | 12.9% |
| P/E (TTM) | 111.9× | — |
| Price / sales | 32.9× | 6.5× |
| Net cash | $782.6M | $619.7M |
| Dividend yield | — | — |
| Volatility (60d) | 32.0% | 34.1% |
| Short % of float | 16.8% | 14.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).